Caldwell Sutter Capital, Inc. Bridge Bio Pharma, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $218 Billion
- Q2 2025
A detailed history of Caldwell Sutter Capital, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 2,200 shares of BBIO stock, worth $119,284. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,200
Previous 2,200
-0.0%
Holding current value
$119,284
Previous $76.1 Million
24.91%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
187MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$1.01 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$894 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$719 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$675 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$503 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.04B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...